Company Overview and News

 
Norfolk Southern’s Traffic Rose in Week 19 on Intermodal Gains

16h marketrealist
In the week ended May 12, major Eastern US rail carrier Norfolk Southern’s (NSC) carload traffic, excluding intermodal volumes, grew 3.8% YoY (year-over-year) to ~73,800 units from ~71,100.

 
The Slow Growth of CSX’s Rail Traffic in Week 19

16h marketrealist
In Week 19, Eastern US major railroad CSX (CSX) rose 1.9% YoY (year-over-year) in carload traffic. It hauled ~72,700 carloads compared to ~71,300 in Week 19 of 2017. Throughout much of 2018, this Florida-based rail giant has reported a YoY decline in railcar traffic. However, in the last few weeks, its carload volumes have shown an upward trend YoY. CSX’s carload volume growth was also much lower than US railroads’ 5.

 
Does Union Pacific’s Free Cash Flow Suggest a Rise in 2018?

2018-05-18 marketrealist
Transportation stocks seem to be back on track in 2018, resulting from two factors. The first factor is the passage of the Tax Cuts and Jobs Act. The provision of deduction capital expenditures for tax calculation purposes in the year incurred has favored transportation (XTN) stocks—specifically the railroads.

 
How Union Pacific’s Dividend Has Varied Historically

2018-05-18 marketrealist
On May 10, Western US rail freight giant Union Pacific (UNP) declared a quarterly cash dividend of $0.73 per share on its common stock. In the first quarter, UNP raised its quarterly cash dividend from $0.665 per share to $0.73 per share. The company’s quarterly cash dividend on equity shares is payable on June 29 to stockholders of record on May 31.

 
Why Genesee and Wyoming Stock Has Been Rising Recently

2018-05-17 marketrealist
Genesee & Wyoming (GWR) is the largest short line carrier in the US and Canada with operations in the US, Canada, UK/Europe, and parts of Australia. Though it’s not a Class I railroad, it is often compared with US Class I railroads.

 
5 Stocks to Skyrocket on Record Memorial Day Travel

2018-05-16 investorplace
A higher number of Americans are gearing up for a busy summer travel season. Be it by road or air, Americans this time are encouraged to travel thanks to a booming economy and growing consumer confidence.

 
5 Stocks to Skyrocket on Record Memorial Day Travel

2018-05-16 zacks
A higher number of Americans are gearing up for a busy summer travel season. Be it by road or air, Americans this time are encouraged to travel thanks to a booming economy and growing consumer confidence.

 
Comparing Norfolk Southern’s Freight Volumes in Week 18

2018-05-15 marketrealist
US rail carrier Norfolk Southern’s (NSC) carload traffic, excluding intermodal, rose by double digits (10.2%) YoY (year-over-year) in Week 18, to ~73,000 units from ~66,200.

1
Which Commodities Boosted UNP’s Freight Traffic in Week 18

2018-05-15 marketrealist
So far this year, Western US rail freight giant Union Pacific’s (UNP) YoY (year-over-year) freight volume growth has lagged behind rival BNSF Railway’s (BRK.B). In Week 18, UNP’s carload traffic rose 5.2% YoY (year-over-year) to ~94,400 carloads (excluding intermodal units) from ~89,800. It underperformed BNSF Railway (BRK.B), whose carload traffic grew 10.7%, and US railroads.

 
How CSX’s Freight Volumes Trended in Week 18

2018-05-15 marketrealist
In Week 18, major eastern US rail carrier CSX’s (CSX) carload traffic fell marginally YoY (year-over-year), by 0.22% to ~69,400 units from ~69,500. Throughout much of 2018, the Florida-based rail giant has reported YoY railcar traffic decline, though it seems to be getting back on track. In contrast, rival Norfolk Southern’s (NSC) carload traffic grew 10.2% in Week 18, and US railroads’ grew 6.4%.

 
Hallador Energy's (HNRG) CEO Brent Bilsland on Q1 2018 Results - Earnings Call Transcript

2018-05-13 seekingalpha
Hallador Energy Company (NASDAQ:HNRG) Q1 2018 Results Earnings Conference Call May 8, 2018 2:00 PM ET

 
FANG Stocks Have Ignited A Rally - Cramer's Mad Money (5/10/18)

2018-05-11 seekingalpha
Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Thursday, May 10.

 
3 Shipping Stocks to Sail Smooth on Likely Q1 Earnings Beat

2018-05-09 zacks
The first-quarter earnings season is well into its latter half with more than 81% of the S&P 500 members having unveiled their quarterly results already. The picture that has emerged so far is quite encouraging and the Q1 earnings season remains on track to end on a strong note, displaying substantial growth.

 
A Summary of Norfolk Southern’s Rail Traffic in Week 17

2018-05-09 marketrealist
In Week 17 of 2018, US rail carrier Norfolk Southern’s (NSC) carload traffic grew 4.2% YoY (year-over-year). In that week, its rail traffic grew YoY from ~71,800 units to ~74,800.

 
CSX versus Norfolk Southern: Rail Traffic in Week 17

2018-05-08 marketrealist
In the 17th week of 2018, rail carrier CSX (CSX) reported a 4.8% carload traffic rise YoY (year-over-year). Throughout much of 2018, the Florida-based rail giant has reported YoY railcar traffic decline. In recent weeks, CSX’s rail traffic has gotten back on track.

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

14h - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

14h - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...

CUSIP: 655844108